SalaryGuide
AboutPricingBlogFor Employers

Marketing jobs

2 marketing jobs

Rapport logo
3 days ago

Marketing Intern, Chartwells Higher Ed / Lamar University

Rapport

Beaumont, TX (Unknown)Internship
Rapport logo
5 weeks ago

Marketing Intern, Chartwells Higher Ed / California State University - Los Angeles

Rapport

Los Angeles, CA (Unknown)Internship

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

2 jobs
Rapport logo

Marketing Intern, Chartwells Higher Ed / Lamar University

Rapport

Beaumont, TX (Unknown)

In-houseInternshipIntern/new grad
3 days ago
Rapport logo

Marketing Intern, Chartwells Higher Ed / California State University - Los Angeles

Rapport

Los Angeles, CA (Unknown)

In-houseInternshipIntern/new grad
5 weeks ago
Rapport logo
Rapport

Marketing Intern, Chartwells Higher Ed / Lamar University

Beaumont, TX (Unknown)

Salary Not AvailableIntern/New GradInternship

Posted 3 days ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own planning and execution of campus marketing initiatives across events, campaigns, and digital content, with research, branding, and promotional tasks guiding the workstreams.

  • Plan and host events and campus activities to engage students.
  • Develop and promote social media campaigns and calendar content.
  • Represent the brand in communications and promotional materials.

Job Description

Responsibilities

  • Assist with planning, organizing and hosting events
  • Assist with Dine on Campus
  • Assist in social media calendar development and promotions
  • Act as a brand representative
  • Conduct marketing audits
  • Conduct general administrative tasks
  • Complete Marketing Boot Camp
  • Surveying students to collect marketing research
  • Create marketing materials to numerous specifications
  • Manage signage in multiple locations

Requirements

  • Excellent communication skills, written and verbal
  • Customer service experience/knowledge
  • Knowledge of social media platforms
  • Good to better interpersonal skills
  • General interest and knowledge
  • Knowledge of graphic design tools is a plus
  • Prior marketing related experience is a plus
  • Event Planning/Execution

Benefits

  • competitive wages, benefits, and perks like Instapay through the One @Work app.
Rapport logo

Rapport

Rapport is AI role-play with lifelike avatars. Your team practices the hard conversations before they're real, and you finally get data on who's ready.Here's the thing about training: completion rates measure recall, not readiness. A rep can know the product perfectly and still lose the room. A new manager can ace every module and still freeze the moment someone says "I was expecting that promotion."Those skills, timing, tone, empathy, judgment, only come from practice. And most people get their practice the expensive way: live, in front of a real customer or a real direct report. Ouch.So we changed where the reps happen.With Rapport, your team rehearses the skeptical buyer, the price objection, the dreaded performance review, or the de-escalation call with AI avatars that react in real time. Real facial expressions. Real nonverbal cues. Not a chatbot with a headshot.Every attempt gets scored against your company's definition of a good conversation. Learners get feedback specific enough to actually change behavior. Managers get skill-by-skill data across the whole team.And the pedigree is real: built by PhD researchers from the University of Edinburgh, with a decade of avatar animation behind major game titles. Nearly 700,000 role-plays run. 50+ languages and dialects.Teams use us for: • Sales enablement and objection handling • Onboarding and new hire ramp • Performance reviews and manager development • Customer success and de-escalation • Industry-specific selling, from SaaS to medical deviceScenarios build in 15 to 20 minutes. SCORM export to any LMS. Useful data from as few as five learners.Stop guessing whether your team is ready. Come see it: https://rapport.cloud/#demo

Founded in 2001
San Francisco, California, USA
27 employees (6 in marketing)
www.rapport.cloud

Traffic Signals

Monthly Visitors
9.1K
Monthly Google Ads Budget
$2.6K

Headcount Trend

Current headcount: ~28

Marketing Team

Marketing Team Size
4 (15% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$25.5M
Last Raise
$18.5M
Series C

Funding History

  • Oct 2007
    Series C • $18.5M
  • Jul 2005
    Series A • $7M

Recent News

TD Cowen Maintains Rapport Therapeutics(RAPP.US) With Buy Rating
Jul 18, 2026 • Moomoo
Revolut and Spotify investor warns Europe over reliance on US tech
Jul 17, 2026 • Financial Times
Enterprise value to revenue forward of Rapport Therapeutics, Inc. – NASDAQ:RAPP
Jul 13, 2026 • TradingView
What Does the Sale of Rapport Therapeutics Stock Worth Over $400,000 by the Chief Operating Officer Mean for Investors?
Jul 12, 2026 • Yahoo Finance
Is Rapport Therapeutics, Inc. (RAPP) A Good Stock To Buy Now?
Jun 16, 2026 • Yahoo Finance
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
Jun 12, 2026 • BioPharma Dive
BTIG Raises its Price Target on Rapport Therapeutics (RAPP)
Jun 5, 2026 • Yahoo Finance
Coinbase Says It Wins Conditional US Approval for Trust Charter
Apr 2, 2026 • Bloomberg.com
New Rapport 2800 tug for Gulf LNG
Apr 2, 2026 • WorkBoat
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
Apr 1, 2026 • Yahoo Finance
Rapport’s RAP-219 gets more phase III funding with Tenacia deal
Mar 10, 2026 • BioWorld MedTech
Rapport Therapeutics stock holds Buy at TD Cowen on China deal
Mar 9, 2026 • Investing.com
Tenacia builds $308M biobucks deal with Rapport to develop epilepsy drug in greater China
Mar 9, 2026 • Fierce Biotech
Rapport Therapeutics and Tenacia Biotechnology Announce Strategic Collaboration for the Development and Commercialization of RAP-219 in Greater China
Mar 9, 2026 • Sahm
War in the Middle East – implications for markets and macro
Mar 2, 2026 • ING THINK economic and financial analysis | ING THINK
'Grounds for Conversation' event helps build rapport between cops, community
Feb 28, 2026 • Citizen Tribune
Rapport Therapeutics to Participate in Upcoming Investor Conferences
Feb 24, 2026 • GlobeNewswire
Rapport Therapeutics (NASDAQ:RAPP) Stock Rating Lowered by Wall Street Zen
Feb 7, 2026 • Defense World
USD₮ Q4 2025 Market Report
Feb 4, 2026 • Tether.io
Rapport Therapeutics (NASDAQ:RAPP) Now Covered by Analysts at Wells Fargo & Company
Feb 3, 2026 • Defense World
Wells Fargo & Company Begins Coverage on Rapport Therapeutics (NASDAQ:RAPP)
Feb 2, 2026 • MarketBeat
Is Rapport Therapeutics Inc. stock a smart buy before Fed meeting - 2025 Sector Review & Free Expert Approved Momentum Trade Ideas
Jan 9, 2026 • ulpravda.ru
Rapport Therapeutics Advances RAP-219 into Phase 3 Trials for Focal Onset Seizures, Expands Epilepsy Portfolio with New Program
Jan 7, 2026 • Quiver Quantitative
Rapport Therapeutics Announces Accelerated Initiation of RAP-219 Phase 3 Program, Expansion of Epilepsy Portfolio, and Continued Progress Across the Pipeline
Jan 7, 2026 • The Manila Times
Have Rapport Therapeutics Insiders Been Selling Stock?
Jan 7, 2026 • Sahm
UK softens stance on farm tax after months of protests
Dec 23, 2025 • Reuters
Kakao Ventures backs Rapport Labs in cash acquisition of SK Stoa - CHOSUNBIZ
Dec 16, 2025 • Chosunbiz
Rapport Acquires Aquifer Motion, Becoming the First Company to Offer Real-Time, AI-Powered Avatars with Full-Body Animation
Oct 7, 2025 • Yahoo Finance
Rapport Acquires Aquifer Motion
Oct 7, 2025 • citybiz
Rapport Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
Sep 10, 2025 • Quiver Quantitative
Rapport Announces Pricing of Public Offering of Common Stock
Sep 9, 2025 • GlobeNewswire
Rapport Jumps 180% on ‘Best Case’ Mid-Stage Data for Epilepsy Pill
Sep 8, 2025 • BioSpace
Rapport shares soar after successful mid-stage seizure trial
Sep 8, 2025 • statnews.com
Rapport's seizure drug hits in phase 2, sending stock soaring
Sep 8, 2025 • Fierce Biotech
Rapport shares double on better-than-expected seizure drug data
Sep 8, 2025 • BioPharma Dive
Rapport Announces Positive Topline Results from Phase 2a
Sep 8, 2025 • GlobeNewswire
Rapport: Surging On Phase 2 Study Win - Full Approval Unlikely Before 2028 (NASDAQ:RAPP)
Sep 8, 2025 • Seeking Alpha
Rapport reveals promising open-label study data for epilepsy pill, heads to Phase 3
Sep 8, 2025 • Endpoints News
Key Epilepsy Drug Trial Results Coming Monday: Rapport's RAP-219 Phase 2a Data Could Impact Treatment
Sep 5, 2025 • Stock Titan
Rapport Therapeutics to Announce Topline Results for
Sep 5, 2025 • GlobeNewswire
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
Jun 2, 2025 • GlobeNewswire
Rapport Bad Bot 2025 d’Imperva : l’IA favorise l’explosion des bots indétectables, dominant le trafic internet mondial
Apr 15, 2025 • standard-journal.com
Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Mar 11, 2025 • Yahoo Finance
Rapport Therapeutics Inc. (RAPP) reports earnings
Mar 11, 2025 • qz.com
New York State Common Retirement Fund Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP)
Mar 7, 2025 • Defense World
PRESENTATION: The State of Video Gaming in 2025
Jan 14, 2025 • MatthewBall.co
Rapport's pain trial hits regulatory stumbling block
Nov 7, 2024 • FirstWord Pharma